Safety of concurrent administration of dexrazoxane and doxorubicin in the canine cancer patient*
Author:
Publisher
Wiley
Subject
General Veterinary
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1476-5829.2010.00225.x/fullpdf
Reference54 articles.
1. Dexrazoxane prevents doxorubicin-induced long-term cardiotoxicity and protects myocardial mitochondria from genetic and functional lesions in rats;Lebrecht;British Journal of Pharmacology,2007
2. Doxorubicin-induced cardiomyopathy from the cardiotoxic mechanisms to management;Takemura;Progress in Cardiovascular Diseases,2007
3. A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin;Gewirtz;Biochemical Pharmacology,1999
4. Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity;Minotti;Pharmacological Reviews,2004
5. Dexrazoxane protects against myelosuppression from the DNA cleavage-enhancing drugs etoposide and daunorubicin but not doxorubicin;Hofland;Clinical Cancer Research,2005
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Cardiomyopathy in a dog with multicentric lymphoma following treatment with several anthracyclines;Open Veterinary Journal;2021-03-19
2. Evaluation of cardioprotective effects of carvedilol in dogs receiving doxorubicin chemotherapy: A prospective, randomized, double-blind, placebo controlled pilot study;Research in Veterinary Science;2021-03
3. Cardiovascular Pharmacotherapeutics;Pharmacotherapeutics for Veterinary Dispensing;2019-02-15
4. Incidence and risk factors associated with development of clinical cardiotoxicity in dogs receiving doxorubicin;Journal of Veterinary Internal Medicine;2019-01-29
5. Substitution of mitoxantrone for doxorubicin in a multidrug chemotherapeutic protocol for first-line treatment of dogs with multicentric intermediate- to large-cell lymphoma;Journal of the American Veterinary Medical Association;2019-01-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3